Target intelligence / Profile preview

PHC2 antisense RNA 1 (PHC2-AS1)

Target
PHC2-AS1
Molecular classification
Noncoding RNA, Long noncoding RNA (lncRNA), Antisense RNA
01

Overview

PHC2 antisense RNA 1 (PHC2-AS1) is a long noncoding RNA transcribed antisense to the PHC2 gene, which encodes a Polycomb group protein involved in assembly and function of the PRC1 chromatin remodeling complex. As an antisense RNA, PHC2-AS1 likely plays a role in regulating gene expression, potentially by modulating the transcription or epigenetic state of PHC2 or neighboring loci. Antisense lncRNAs are broadly implicated in epigenetic regulation, silencing, and cellular differentiation, notably within cancer biology and developmental processes, though there are no direct functional studies of PHC2-AS1 to date. PHC2-AS1 is not classically considered a receptor, enzyme, or transporter but belongs to the noncoding regulatory RNA family. There is currently no evidence of direct drug interaction or biomarker utility, but ongoing research in antisense RNA mechanisms could expand its relevance to therapeutic development. If more specific disease associations or mechanisms are discovered for PHC2-AS1, structured annotations should be updated accordingly.

Other names
PHC2-AS1PHC2 antisense RNA 1
02

Mechanism of action

RNA-based mechanisms typical for lncRNAs, such as transcriptional interference, chromatin remodeling, or epigenetic silencing, based on broader antisense RNA functions rather than PHC2-AS1-specific data

03

Biological functions

Gene expression regulationEpigenetic regulationChromatin modification
04

Disease associations

CancerOther
05

Safety considerations

None noted specifically for PHC2-AS1; general therapeutic challenges for lncRNAs include off-target effects, delivery, and specificity

Beyond the preview

Go deeper on PHC2 antisense RNA 1 (PHC2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHC2 antisense RNA 1 (PHC2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call